Viewing data from:

FELODIPINE

ANDA

FELODIPINE | A090365 | GLENMARK PHARMACEUTICALS LTD

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.1194

per ea

Lowest NADAC/Unit

$0.1117

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68462023401FELODIPINE ER 5 MG TABLET	$0.1194	EA	Generic	—	2026-06-17
68462023301FELODIPINE ER 2.5 MG TABLET	$0.1123	EA	Generic	—	2026-06-17
68462023501FELODIPINE ER 10 MG TABLET	$0.1117	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain8 active DMFs10 inactive

8 active API suppliers hold Drug Master Files for this ingredient.

CIPLA LTDFELODIPINE USP

DMF 114491995

MEDICHEM SAFELODIPINE

DMF 140991999

EVERLIGHT CHEMICAL INDUSTRIAL CORPFELODIPINE

DMF 170302003

ZHEJIANG SUPOR PHARMACEUTICALS CO LTDFELODIPINE, NON-STERILE DRUG SUBSTANCE USP

DMF 194492006

APITORIA PHARMA PRIVATE LTDFELODIPINE USP, NON-STERILE DRUG SUBSTANCE

DMF 208902007

ORBION PHARMACEUTICALS PRIVATE LTDFELODIPINE (NON-STERILE BULK API)

DMF 213542008

ALEMBIC PHARMACEUTICALS LTDFELODIPINE USP

DMF 253732011

LAKSH FINE CHEM PRIVATE LTDFELODIPINE EP/BP/USP/JP

DMF 436002026

ESTEVE QUIMICA SAInactiveFELODIPINE

DMF 122481996

WOCKHARDT LTDInactiveFELODIPINE

DMF 132551998

YANGZHOU PHARMACEUTICAL FACTORYInactiveFELODIPINE

DMF 147862000

PCASInactiveFELODIPINE

DMF 185102005

YANGZHOU PHARMACEUTICAL CO LTDInactiveFelodipine USP

DMF 210512007

KOREA UNITED PHARMACEUTICALS INCInactiveFELODIPINE

DMF 216642008

HAINAN POLY PHARMACEUTICAL CO LTDInactiveFELODIPINE EXTENDED RELEASE TABLETS

DMF 237242010

EMCURE PHARMACEUTICALS LTDInactiveFELODIPINE USP

DMF 246812011

CHANGZHOU RUIMING PHARMACEUTICAL CO LTDInactiveFELODIPINE

DMF 254052011

HEC PHARM USA INCInactiveFELODIPINE NON-STERILE BULK DRUG SUBSTANCE

DMF 268112013

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 2.5MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Dec 17, 2010

No patent or exclusivity listings for this strength.

#002 — 5MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Dec 17, 2010

#003 — 10MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Dec 17, 2010